Abstract
Background
Shivering during induced normothermia (IN) remains a therapeutic limitation. We investigated potential risk factors and clinical implications of shivering during IN.
Methods
Post hoc analysis was performed on 24 patients enrolled in a clinical trial of an automated surface cooling system to achieve IN. Hyponatremia was defined as serum levels <136 mmol/L and hypomagnesaemia as levels <1.5 mg/dL. Continuous heat energy transfer (kcal/h) was averaged hourly. Glasgow Coma Scale (GCS) scores were recorded every 2 h. Shivering status was documented hourly. Mixed effects modeling was used to determine clinical measures associated with shivering. Generalized estimating equation (GEE) models were used to compare baseline-adjusted repeated-measures GCS scores.
Results
About of 24 (39%) patients demonstrated shivering. Shivering was associated with men (67% vs. 21%, P = 0.03), hyponatremia (44% vs. 7%, P = 0.03), and hypomagnesaemia (56% vs. 7%, P = 0.02). The average kcal/h (158 ± 645 kcal/h vs. 493 ± 645 kcal/h, P = 0.03) was greater in shivering patients. Shivering was positively associated with increases in heart rate (P < 0.001), respiratory rate (P < 0.001), and kcal/h (P < 0.001). Non-shivering patients showed a greater increase from baseline GCS (GEE, P = 0.02) at 24 h. No differences in sedative doses or fever burden were noted between shiverers and non-shiverers.
Conclusions
Men, hyponatremia, and hypomagnesaemia may predispose febrile patients treated with IN to shivering. Shivering dramatically increases the amount of heat transfer required to maintain normothermia, and may be associated with adverse effects on level of consciousness.
Similar content being viewed by others
References
Albrecht RF 2nd, Wass CT, Lanier WL. Occurrence of potentially detrimental temperature alterations in hospitalized patients at risk for brain injury. Mayo Clin Proc 1998;73(7):629–35.
Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001;56(10):1299–304.
Jiang JY, Gao GY, Li WP, Yu MK, Zhu C. Early indicators of prognosis in 846 cases of severe traumatic brain injury. Journal of Neurotrauma 2002;19(7):869–74.
Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000;54(2):354–61.
Kasner SE, Wein T, Piriyawat P, et al. Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial.[see comment]. Stroke 2002;33(1):130–4.
Koennecke HC, Leistner S. Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke: a pilot study. Neurology 2001;57(12):2301–3.
O’Donnell J, Axelrod P, Fisher C, Lorber B. Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit.[see comment]. Clin Infect Dis 1997;24(6):1208–13.
Carhuapoma JR, Gupta K, Coplin WM, Muddassir SM, Meratee MM. Treatment of refractory fever in the neurosciences critical care unit using a novel, water-circulating cooling device. A single-center pilot experience. J Neurosurg Anesthesiol 2003;15(4):313–8.
Diringer MN. Neurocritical Care Fever Reduction Trial G. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004;32(2):559–64.
Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.[see comment]. Crit Care Med 2004;32(12):2508–15.
Badjatia N, O’Donnell J, Baker JR, et al. Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter. Neurocrit Care 2004;1(2):145–56.
Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study.[see comment]. Crit Care Med 2002;30(11):2481–8.
De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology 2002;96(2):467–84.
Sessler DI. Perioperative thermoregulation and heat balance. Ann N Y Acad Sci 1997;813:757–77.
Lee DS, Shaffer MJ. Low incidence of shivering with chronic propranolol therapy. Lancet 1986;1(8479):500.
Eberhart LH, Doderlein F, Eisenhardt G, et al. Independent risk factors for postoperative shivering. Anesth Analg 2005;101(6):1849–57.
Wagner JA, Horvath SM. Influences of age and gender on human thermoregulatory responses to cold exposures. J Appl Physiol 1985;58(1):180–6.
Hubbard RW. Heatstroke pathophysiology: the energy depletion model. Med Sci Sports Exerc 1990;22(1):19–28.
Myers RD, Veale WL. The role of sodium and calcium ions in the hypothalamus in the control of body temperature of the unanaesthetized cat. J Physiol 1971;212(2):411–30.
Myers RD, Yaksh TL. Thermoregulation around a new set-point’ established in the monkey by altering the ratio of sodium to calcium ions within the hypothalamus. J Physiol 1971;218(3):609–33.
Kizilirmak S, Karakas SE, Akca O, et al. Magnesium sulfate stops postanesthetic shivering. Ann N Y Acad Sci 1997;813:799–806.
Zweifler RM, Voorhees ME, Mahmood MA, Parnell M. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke 2004;35(10):2331–4.
Kranke P, Eberhart LH, Roewer N, Tramer MR. Pharmacological treatment of postoperative shivering: a quantitative systematic review of randomized controlled trials.[see comment]. Anesth Analg 2002;94(2):453–60.
Wadhwa A, Sengupta P, Durrani J, et al. Magnesium sulphate only slightly reduces the shivering threshold in humans. Br J Anaesth 2005;94(6):756–62.
Crossley AW, Mahajan RP. The intensity of postoperative shivering is unrelated to axillary temperature. Anaesthesia 1994;49(3):205–7.
Headley JM. Indirect calorimetry: a trend toward continuous metabolic assessment. AACN Clin Issues 2003;14(2):155–67 quiz 266.
Author information
Authors and Affiliations
Corresponding author
Appendix : A Calculation of Heat Energy Transfer
Appendix : A Calculation of Heat Energy Transfer
In equation form:
where qu = uncorrected heat transfer rate (kcal/hour), σ = density of water (=1 kg/l), Cp = heat capacity of water (= 1 kcal/(kgoC)) and 60 = conversion factor (per minute to per hour). As defined in the above equation heat being removed from the patient is positive.
The heat transfer rate then was corrected for ambient losses. The ambient heat losses were comprised of energy lost from the fluid supply lines and energy lost from the Energy Transfer pads. To measure the ambient heat loss from the fluid supply line, calibrated in line thermistor probes were attached to the supply and return ports of the Arctic Sun and the proximal end of fluid supply line was attached to these probes. Shunts were connected to three of the five sets of connector ports at the distal end of the fluid supply line. The temperature probes were connected to a Cole Parmer Thermistor Thermometer. An ambient probe also was connected to the Thermistor Thermometer. The Arctic Sun was operated in Manual Mode with a water target of 4°C and 42°C. The ambient heat loss from the fluid delivery line was computed as:
where hl × Al = heat transfer coefficient normalized for surface area (kcal/h(C) and Ta = ambient temperature (oC). The value of the fluid delivery line heat loss was:
The energy loss from the Energy Transfer Pads was determined on two volunteers that had a full set of five Energy Transfer Pads applied. Heat loss was measured using Concept Engineering Heat Flow Sensors and was recorded directly in kcal/m2 mV. The subjects were laying supine in a hospital bed and were covered with a light blanket. Heat flux transducers were placed on pads covering the thighs, back, and abdomen. Measurements were area averaged and averaged for the two subjects to give a pad ambient heat transfer coefficient of:
where qp = pad heat loss (kcal/h).
The corrected heat transfer rate was computed as:
The total energy removed from a patient was computed as the integral of the corrected heat transfer rate over time. In equation form:
where qc,i = corrected heat transfer rate (kcal/min) and Δti = time interval ( = 1 min).
Rights and permissions
About this article
Cite this article
Badjatia, N., Kowalski, R.G., Schmidt, J.M. et al. Predictors and clinical implications of shivering during therapeutic normothermia. Neurocrit Care 6, 186–191 (2007). https://doi.org/10.1007/s12028-007-0011-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-007-0011-2